Figure 3From: Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumorsCumulative survival curves of the R, NR, H and EH subgroups in the HCC group. Survival: months, R: responder, NR: nonresponder, H: hepatic, EH: extrahepatic.Back to article page